$1.15
8.55% today
Nasdaq, Feb 28, 05:19 pm CET
ISIN
US92731L1061
Symbol
VINC
Sector
Industry

Vincerx Pharma Inc Stock price

$1.26
-0.73 36.62% 1M
-14.14 91.82% 6M
-4.00 76.03% YTD
-79.74 98.44% 1Y
-100.14 98.76% 3Y
-185.74 99.33% 5Y
-185.74 99.33% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
+0.17 15.60%
ISIN
US92731L1061
Symbol
VINC
Sector
Industry

Key metrics

Market capitalization $2.82m
Enterprise Value $-5.71m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.20
P/B ratio (TTM) P/B ratio 0.22
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-28.17m
Free Cash Flow (TTM) Free Cash Flow $-27.97m
Cash position $10.17m
EPS (TTM) EPS $-20.62
Short interest 3.00%
Show more

Is Vincerx Pharma Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Vincerx Pharma Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Vincerx Pharma Inc forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a Vincerx Pharma Inc forecast:

Buy
100%

Financial data from Vincerx Pharma Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
- -
-
100%
- Direct Costs 1.07 1.07
19% 19%
-
-1.07 -1.07
19% 19%
-
- Selling and Administrative Expenses 11 11
25% 25%
-
- Research and Development Expense 15 15
58% 58%
-
-27 -27
47% 47%
-
- Depreciation and Amortization 1.07 1.07
19% 19%
-
EBIT (Operating Income) EBIT -28 -28
46% 46%
-
Net Profit -27 -27
45% 45%
-

In millions USD.

Don't miss a Thing! We will send you all news about Vincerx Pharma Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Vincerx Pharma Inc Stock News

Neutral
GlobeNewsWire
about one month ago
Vincerx's Common Stock to Begin Trading on a Split-adjusted Basis on January 28, 2025 Vincerx's Common Stock to Begin Trading on a Split-adjusted Basis on January 28, 2025
Neutral
Business Wire
about 2 months ago
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Vincerx Pharma, Inc. (NasdaqCM: VINC) and Oqory, Inc. Pursuant to the terms of the agreement, at the closing of the transaction, Vincerx equity holders will hold about 5% of the combined company. KSF is seeking ...
Neutral
Business Wire
2 months ago
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Vincerx Pharma, Inc. (NASDAQ: VINC) and Oqory, Inc. is fair to Vincerx shareholders. Upon completion of the proposed transaction, Vincerx equity holders will hold about 5% of the combined company. Halper Sadeh encourages Vincerx shareholders to click here to learn more about their le...
More Vincerx Pharma Inc News

Company Profile

Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. It focuses on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The firm pipeline is derived from a license agreement with Bayer and includes: a clinical-stage and follow-on small molecule drug program and preclinical stage bioconjugation/next-generation antibody-drug conjugate platform. The company was founded by Ahmed Hamdy, Raquel Izumi, Tom Thomas, Stuart Hwang, and John Byrd in 2018 and is headquartered in Palo Alto, CA.

Head office United States
CEO Raquel Izumi
Employees 42
Founded 2018
Website vincerx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today